Literature DB >> 31004178

A high-cholesterol diet promotes steatohepatitis and liver tumorigenesis in HCV core gene transgenic mice.

Xiaojing Wang1,2, Naoki Tanaka3,4, Xiao Hu1,5, Takefumi Kimura6, Yu Lu1, Fangping Jia1, Yoshiko Sato7, Jun Nakayama7, Kyoji Moriya8, Kazuhiko Koike9, Toshifumi Aoyama1.   

Abstract

Previous epidemiological studies have suggested a link between high-cholesterol intake and liver disease progression, including hepatocellular carcinoma (HCC). However, the precise mechanism of hepatotoxicity and hepatocarcinogenesis caused by excessive cholesterol consumption remains unclear. We aimed to investigate the impact of dietary cholesterol using hepatitis C virus core gene transgenic (HCVcpTg) mice, which spontaneously developed HCC with age. Male HCVcpTg mice were treated for 15 months with either a control diet or an isocaloric diet containing 1.5% cholesterol, and liver phenotypes and tumor-associated signaling pathways were evaluated. The high-cholesterol diet-fed HCVcpTg mice exhibited a significantly higher incidence of liver tumors compared with the control diet mice (100% vs. 41%, P < 0.001). The diet induced steatohepatitis with pericellular fibrosis and evoked higher mRNA expression of pro-inflammatory and pro-fibrotic mediators along with enhanced hepatocyte proliferation and greater oxidative and endoplasmic reticulum stress in the liver. Moreover, long-term consumption of cholesterol-rich diet activated nuclear factor-kappa B (NF-κB) and p62/sequestosome 1 (Sqstm1)-nuclear factor erythroid 2 (NRF2) axis, enhanced fibrogenesis, and consequently accelerated hepatic tumorigenesis. In conclusion, these results demonstrate that a high-cholesterol diet facilitates liver tumorigenesis by inducing steatohepatitis, promoting hepatocyte division, and up-regulating cellular stress and pro-inflammatory NF-κB and detoxifying p62/Sqstm1-NRF2 signals. Therefore, high dietary cholesterol should be avoided in HCV-infected patients to prevent development of steatohepatitis, liver fibrosis, and HCC.

Entities:  

Keywords:  Fibrogenesis; NF-κB; Oxidative stress; Steatohepatitis; p62/Sqstm1-NRF2 axis

Mesh:

Substances:

Year:  2019        PMID: 31004178     DOI: 10.1007/s00204-019-02440-7

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  2 in total

1.  PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.

Authors:  Naoki Tanaka; Kyoji Moriya; Kendo Kiyosawa; Kazuhiko Koike; Frank J Gonzalez; Toshifumi Aoyama
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

2.  Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma.

Authors:  Satoshi Ogura; Yuichi Yoshida; Tomohide Kurahashi; Mayumi Egawa; Kunimaro Furuta; Shinichi Kiso; Yoshihiro Kamada; Hayato Hikita; Hidetoshi Eguchi; Hisakazu Ogita; Yuichiro Doki; Masaki Mori; Tomohide Tatsumi; Tetsuo Takehara
Journal:  Oncotarget       Date:  2018-04-20
  2 in total
  7 in total

1.  Dietary Restriction Suppresses Steatosis-Associated Hepatic Tumorigenesis in Hepatitis C Virus Core Gene Transgenic Mice.

Authors:  Fangping Jia; Pan Diao; Xiaojing Wang; Xiao Hu; Takefumi Kimura; Makoto Nakamuta; Ibuki Nakamura; Saki Shirotori; Yoshiko Sato; Kyoji Moriya; Kazuhiko Koike; Frank J Gonzalez; Jun Nakayama; Toshifumi Aoyama; Naoki Tanaka
Journal:  Liver Cancer       Date:  2020-07-10       Impact factor: 11.740

2.  A saturated fatty acid-rich diet enhances hepatic lipogenesis and tumorigenesis in HCV core gene transgenic mice.

Authors:  Pan Diao; Xiaojing Wang; Fangping Jia; Takefumi Kimura; Xiao Hu; Saki Shirotori; Ibuki Nakamura; Yoshiko Sato; Jun Nakayama; Kyoji Moriya; Kazuhiko Koike; Frank J Gonzalez; Toshifumi Aoyama; Naoki Tanaka
Journal:  J Nutr Biochem       Date:  2020-07-03       Impact factor: 6.048

3.  Dapagliflozin attenuates cholesterol overloading-induced injury in mice hepatocytes with type 2 diabetes mellitus (T2DM) via eliminating oxidative damages.

Authors:  Liu Yang; Dan Liu; Hongqin Yan; Kaixia Chen
Journal:  Cell Cycle       Date:  2022-01-31       Impact factor: 4.534

Review 4.  The Role of Chaperone-Mediated Autophagy in Hepatitis C Virus-Induced Pathogenesis.

Authors:  Chieko Matsui; Putu Yuliandari; Lin Deng; Takayuki Abe; Ikuo Shoji
Journal:  Front Cell Infect Microbiol       Date:  2021-12-02       Impact factor: 5.293

Review 5.  Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.

Authors:  Takefumi Kimura; Simran Singh; Naoki Tanaka; Takeji Umemura
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-06       Impact factor: 5.555

Review 6.  Viral Hepatitis, Cholesterol Metabolism, and Cholesterol-Lowering Natural Compounds.

Authors:  Je-Wen Liou; Hemalatha Mani; Jui-Hung Yen
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

Review 7.  Chaperone-Mediated Autophagy in the Liver: Good or Bad?

Authors:  Srikanta Dash; Yucel Aydin; Krzysztof Moroz
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.